Progress Update on Trials

RNS Number : 7735A
MyCelx Technologies Corporation
01 October 2015
 

MYCELX TECHNOLOGIES CORPORATION (AIM: MYX)

       Progress Update on Trials

 

MYCELX Technologies Corporation ("MYCELX" or the "Company"), the clean water technology and engineering company providing patented solutions to the Oil and Gas industry and other commercial industrial markets worldwide, is pleased to provide an update on trials relating to Enhanced Oil Recovery opportunities in India.

 

MYCELX has been undertaking trials to increase its presence in the Enhanced Oil Recovery ("EOR") market segment and is actively pursuing opportunities in India, the Middle East and Canada. The Company reports that it has received a new purchase order for a paid trial to verify a further application of MYCELX products in the treatment of produced water at EOR operations. MYCELX sees this trial as the next important step in verifying its technological advantage and in its pursuit of establishing its presence in India. The paid trial was an expected next step for this ongoing project and underpins revenue projections and the Company expects to be able to report on the progress of the trial in Q1 2016.

 

 

For further information please contact:

 

MYCELX Technologies Corporation

Connie Mixon, CEO

Kimberly Slayton,  Interim CFO

 

Tel: 1 888 306 6843

RFC Ambrian Limited

Corporate Finance

Samantha Harrison

Alexander Millar

 

Corporate Broking

Jonathan Williams

Kim Eckhof

Tel: 44 20 3440 6800

 

Numis Securities Limited

Corporate Broking

James Black

Ben Stoop

Tel: 44 20 7260 1000

 

Bell Pottinger

Nick Lambert

Henry Lerwill

Tel: 44 20 7861 3232

 

 

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSDUFDSFISEEU
UK 100

Latest directors dealings